Abstract:Osteoporosis is one of the most common diseases affecting bone metabolism. Nitric oxide (NO), an endogenous gas molecule involved in osteogenesis, can effectively promote the proliferation and differentiation of osteoblasts. Although exogenous NO can reverse osteoporosis to a certain extent, the transitory half-life and short diffusion radius of NO severely limit its application. In this work, a gas generation nanoplatform of NO with bone targeting property (UCPA) is developed based on the upconversion nanoparticles (UCNPs) that can convert 808 nm near-infrared (NIR) light into UV/blue light, and further stimulate the NO donor (BNN) to release NO. With an adjustment of the output power of the 808 nm NIR, the amount of released NO can be precisely controlled. Both in vitro and in vivo experiments demonstrate the favorable affinity of UCPA to bone due to the modification of alendronate; thus, it can directly release NO in bone and reverse osteoporosis. In addition, the cellular uptake of nanocomposites and intracellular NO release can be observed in preosteoblasts, thereby promoting their differentiation efficiently.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.1c04974.TEM, HRTEM, and HAADF-STEM images, Zeta potential data, isotherm data, pore size distribution data, TGA data; FT-IR, UV–vis, and UCL spectra, photo of reaction products, plots of data related to statistical analysis, fluorescence imaging (PDF)This article has not yet been cited by other publications.

Azide-Dye Unexpected Bone Targeting for Near-Infrared Window II Osteoporosis Imaging

Quasi-dendritic sulfonate-based organic small molecule for high-quality NIR-II bone-targeted imaging

Azaphosphinate Dyes: A Low Molecular Weight Near‐Infrared Scaffold for Development of Photoacoustic or Fluorescence Imaging Probes

Bone disease imaging through the near-infrared-II window

Near-Infrared Contrast Agents for Bone-Targeted Imaging

Biocompatible organic dots with aggregation-induced emission for in vitro and in vivo fluorescence imaging

Aggregation-induced red-NIR emission organic nanoparticles as effective and photostable fluorescent probes for bioimaging

An NIR-II Probe with High PSMA Affinity Demonstrates an Unexpected Excellent Bone Imaging Ability

Near-Infrared Light and Upconversion Nanoparticle Defined Nitric Oxide-Based Osteoporosis Targeting Therapy

Carbonic Anhydrase Inhibitor-decorated Semiconducting Oligomer Nanoparticles for Active-Targeting NIR-II Fluorescence Tumor Imaging

In Vivo Live Imaging of Bone Using Shortwave Infrared Fluorescent Quantum Dots

Quaternary Ammonium Salt Based NIR‐II Probes for In Vivo Imaging

Molecular engineering of a high quantum yield NIR-II molecular fluorophore with aggregation-induced emission (AIE) characteristics for in vivo imaging.

Nanoparticles Passive Targeting Allows Optical Imaging of Bone Diseases

High resolution osteoclast-targeted imaging-guided osteoporosis alleviation via persistent luminescence nanocomposite

Novel aza-BODIPY based small molecular NIR-II fluorophores for in vivo imaging.

A Small-Molecule Diketopyrrolopyrrole-Based Dye for in vivo NIR-IIa Fluorescence Bioimaging

A small-molecule dye for NIR-II imaging

NIR-II Fluorescence Imaging Reveals Bone Marrow Retention of Small Polymer Nanoparticles

NIR-II Ratiometric Lanthanide-Dye Hybrid Nanoprobes Doped Bioscaffolds for In Situ Bone Repair Monitoring

A high quantum yield molecule-protein complex fluorophore for near-infrared II imaging